Table 2.
Asthma Outcomes Reported at Follow-up
| Variables Mean (SD), N (%) |
TEAM-ED | eUC | Estimate (95%CI) |
|---|---|---|---|
| Mean # symptom-free days over 2 weeks (range 0–14) at all follow-ups | 9.97 (3.5) | 10.2 (3.5) | −.026 (−.654, .602) |
| Mean # days with symptoms over 2 weeks (range 0–14) at all follow-ups | 3.14 (3.0) | 3.12 (3.1) | −.118 (−.681, .446) |
| Mean # nights with symptoms over 2 weeks (range 0–14) at all follow-ups | 1.81 (2.4) | 1.71 (2.5) | .086 (−.369, .541) |
| Sum of missed school days due to asthma over the past year | 5.60 (7.9) | 7.20 (13.6) | .901 (.668, 1.217)* |
| ≥1 Unanticipated asthma visit during study year (emergency, urgent care, hospitalization) | 83 (46%) | 84 (48%) | .708 (.501, 1.00)^ |
| Mean caregiver quality of life score (3 and 12 months, range 1–7) | 6.14 (.96) | 6.15 (.90) | .050 (−.133, .232) |
Analysis adjusted for: age, sex, enrollment site, baseline symptoms, preventive medication use at baseline, bi-lingual language, smoke exposure, insurance, pre-pandemic
^
Estimate represents an adjusted rate ratio and 95% confidence intervals.
*
Estimate represents an adjusted odds ratio and 95% confidence intervals